Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASC-J9 cream in facial acne vulgaris
NCT00525499Phase 2Completed
- Sponsor
- AndroScience
- Start
- Aug 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dimethylcurcumin in acne vulgaris (4 arms), sponsored by AndroScience. Primary endpoint: Percent Change in Inflammatory Acne Lesion Counts From Baseline to Week 12. Started Aug 2007; status: completed.
02
Drugs
dimethylcurcumin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00525499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525499.